PhRMA is the lone major trade group not supporting President Trump's new North American trade deal after the drug industry lost crucial intellectual property protections in the agreement. The loss was a blow to a powerful industry group that has long held sway in Washington.
Trending:
PhRMA opposes trade deal over lost drug protections